You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
遠大醫藥(00512.HK)全球創新放射性產品在歐洲獲批新增適應症CE標誌認證

格隆匯9月8日丨遠大醫藥(00512.HK)公告,集團的聯營公司SirtexMedicalPtyLtd的SIR-Spheres釔[90Y]微球注射液(易甘泰)近日在歐洲獲批新適應症的CE標誌認證,用於肝癌患者治療。此次批準新增適應症使該療法的適用範圍在原有的不可切除肝細胞癌(「HCC」)和不可切除結直腸癌肝轉移(「mCRC」)的基礎上,擴展到不可切除肝內膽管癌(「ICC」)、神經內分泌瘤引起的肝轉移(「mNET」)或其他肝轉移等多重適應症,涵蓋的原發性肝癌和繼發性肝轉移的分類更全面。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account